Clinical Trials Sponsored by National Institute of Allergy and Infectious Diseases (NIAID)

Total 3423 results

National Institute of Allergy and Infectious Diseases...
Allergan

Withdrawn

Study to Evaluate the Effects of Cenicriviroc Mesylate on Arterial Inflammation in People Living With HIV

HIV Infections
National Institute of Allergy and Infectious Diseases...

Recruiting

Safety and Immunogenicity of an Inactivated West Nile Virus Vaccine in Healthy Adults

West Nile Viral Infection

United States
National Institute of Allergy and Infectious Diseases...

Recruiting

Efficacy Study of IM Administered CssBA+dmLT Against Moderate-severe Diarrhea in Human Infection Model With ETEC Strain B7A in Healthy Adults

Escherichia Infection

United States
National Institute of Allergy and Infectious Diseases...

Recruiting

CROSSOVER STUDY OF ON-DEMAND PREP FORMULATIONS COMPARING RECTAL AND ORAL TENOFOVIR

Tenofovir

United States
National Institute of Allergy and Infectious Diseases...

Recruiting

Expanding Liver Transplant Immunosuppression Minimization Via Everolimus (ELIMINATE)

Liver Transplant

United States
National Institute of Allergy and Infectious Diseases...

Recruiting

Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates (COLT)

Liver Transplant

United States
National Institute of Allergy and Infectious Diseases...

Recruiting

Advancing Transplantation Outcomes in Children (ADVANTage)

Kidney Transplant

United States, Canada
National Institute of Allergy and Infectious Diseases...

Recruiting

A Study to Evaluate the Safety and Immunogenicity of Two Doses of DCVC H1 HA mRNA-LNP in Healthy Adults

Influenza

United States
National Institute of Allergy and Infectious Diseases...

Recruiting

Assessment of Biomarker-Guided CNI Substitution In Kidney Transplantation

Kidney Transplant

United States
National Institute of Allergy and Infectious Diseases...

Recruiting

A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission

Acute HIV Infection

United States, Brazil, Peru
National Institute of Allergy and Infectious Diseases...

Recruiting

Study of Oral TLR8 Agonist Selgantolimod on HBsAg in Participants With Both Chronic Hepatitis B and HIV

HIV Infections | Hepatitis B

Botswana, United States, Zimbabwe, Haiti, Philippines, Thailand, Brazil, Peru, South Africa, Uganda
National Institute of Allergy and Infectious Diseases...

Recruiting

Neonatal Phase 1 Valacyclovir Study

Herpes Simplex

United States
National Institute of Allergy and Infectious Diseases...

Recruiting

Registry of Asthma Characterization and Recruitment 3 (RACR3) (RACR3)

Asthma

United States
National Institute of Allergy and Infectious Diseases...

Recruiting

The Effect of Helminth Infection Plus COVID-19 Infection on the Immune Response and Intestinal Microorganisms

COVID-19

India
National Institute of Allergy and Infectious Diseases...

Completed

Trial to Evaluate the Immunogenicity of Dose Reduction Strategies of the MVA-BN Monkeypox Vaccine

Monkeypox

United States
National Institute of Allergy and Infectious Diseases...

Active, not recruiting

A Study to Evaluate the Safety and Immunogenicity of a Single Dose of H1ssF-3928 mRNA-LNP in Healthy Adults

Influenza

United States
National Institute of Allergy and Infectious Diseases...

Completed

Evaluation of Two Zika Viruses for Use in Controlled Human Infection Models (CHIM)

Zika Virus

United States
National Institute of Allergy and Infectious Diseases...

Completed

Safety Study of Intravenous Ertapenem in Combination With Zidebactam (WCK 6777)

Bacterial Infection

United States
National Institute of Allergy and Infectious Diseases...

Completed

Phase 4 Comparative Trial of Benzathine Penicillin G for Treatment of Early Syphilis in Subjects With or Without HIV Infection

Syphilis

United States
National Institute of Allergy and Infectious Diseases...

Active, not recruiting

Trial to Evaluate the Safety and Immunogenicity of a Modified Vaccinia Ankara (MVA)-Based Anti-Cytomegalovirus (CMV) Vaccine (Triplex®)

HIV Infections | Cytomegalovirus Infections | Vaccine

United States
National Institute of Allergy and Infectious Diseases...

Completed

Anthrax AV7909 Liquid vs Lyophilized

Anthrax | Anthrax Immunisation

United States
National Institute of Allergy and Infectious Diseases...

Terminated

Pretomanid in Adults With Hepatic Impairment

Tuberculosis

United States
National Institute of Allergy and Infectious Diseases...

Completed

Inpatient Challenge Study of rRSV A/Maryland/001/11, a Human Respiratory Syncytial Virus Challenge Strain, Administered to Healthy Adult Volunteers

Respiratory Syncytial Virus Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

Safety of Intravenous Apramycin in Adults

Bacterial Infection

United States
National Institute of Allergy and Infectious Diseases...

Completed

Safety, Tolerability and Acceptability of Long-Acting Cabotegravir (CAB LA) for the Prevention of HIV Among Adolescent Males

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

Trial to Evaluate the Safety, Immunogenicity and Protective Efficacy of Three or Five Administrations of GAP3KO Sporozoites

Plasmodium Falciparum Infection

United States
National Institute of Allergy and Infectious Diseases...

Terminated

Safety Study of SLV213 for the Treatment of COVID-19.

COVID-19

United States
National Institute of Allergy and Infectious Diseases...

Terminated

Examining Distinct Immunophenotypes to Validate and Enhance Rational Treatment in Systemic Lupus (DIVERT)

Systemic Lupus Erythematosus

United States
National Institute of Allergy and Infectious Diseases...

Completed

A Safety Trial to Test MVA-BN(R)-Filo and Ad26.ZEBOV Vaccines in Healthy Volunteers

Ebola Disease | Marburg Disease

United States
National Institute of Allergy and Infectious Diseases...

Completed

A Clinical Trial in Healthy, HIV-1-Uninfected Adult Participants to Compare the Safety, Tolerability and Immunogenicity of CH505TF gp120 Produced From Stably Transfected Cells to CH505TF gp120 Produced From Transiently Transfected Cells

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

Clofazimine- and Rifapentine-Containing Treatment Shortening Regimens in Drug-Susceptible Tuberculosis: The CLO-FAST Study

HIV | Tuberculosis

Haiti, Zimbabwe, Malawi, South Africa, India
National Institute of Allergy and Infectious Diseases...

Completed

Evaluating the Safety and Immunogenicity of EnvSeq-1 and CH505 M5 gp120 Envs Adjuvanted With GLA-SE in Healthy, HIV-Uninfected Adults

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

Flublok or Fluzone With Advax-CpG55.2 or AF03

Influenza | Influenza Immunisation

United States
National Institute of Allergy and Infectious Diseases...

Completed

A Trial to Evaluate the Safety and Systems Biology Response of Ebolavirus Zaire Vaccine (ChAd3-EBO-Z)

Ebola Disease | Immunisation

United States
National Institute of Allergy and Infectious Diseases...

Completed

Safety and Immunogenicity of pDNA Vaccines Expressing HIV M Group p24^Gag Conserved Elements and/or p55^Gag, Administered With IL-12 pDNA (HVTN119)

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

NNITS-Nitazoxanide for Norovirus in Transplant Patients Study

Gastroenteritis Norovirus

United States
National Institute of Allergy and Infectious Diseases...

Completed

A Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of MVA-BN Yellow Fever Vaccine With and Without Montanide ISA-720 Adjuvant in 18-45 Year Old Healthy Volunteers

Yellow Fever | Yellow Fever Immunisation

United States
National Institute of Allergy and Infectious Diseases...

Completed

rCSP/AP10-602 [GLA-LSQ] Vaccine Trial

Plasmodium Falciparum Infection

United States
National Institute of Allergy and Infectious Diseases...

Completed

ACTIV-5 / Big Effect Trial (BET-B) for the Treatment of COVID-19

COVID-19

United States, Korea, Republic of
National Institute of Allergy and Infectious Diseases...

Completed

Evaluating the Safety and Antiviral Activity of Monoclonal Antibody VRC01 in Infants With HIV Receiving Combination Antiretroviral Therapy

HIV Infections

Botswana, Malawi, Zimbabwe, Brazil
National Institute of Allergy and Infectious Diseases...

Completed

ACTIV-5 / Big Effect Trial (BET-A) for the Treatment of COVID-19

COVID-19

United States
National Institute of Allergy and Infectious Diseases...

Completed

Phase I, Randomized, Double-blinded, Placebo-Controlled Dose De-escalation Study to Evaluate Safety and Immunogenicity of Alum Adjuvanted Zika Virus Purified Inactivated Vaccine (ZPIV) in Adults in a Flavivirus Endemic Area

Zika Virus Infection

Puerto Rico
National Institute of Allergy and Infectious Diseases...

Terminated

Asymptomatic Congenital CMV Treatment

Congenital Cytomegalovirus Infection

United States
National Institute of Allergy and Infectious Diseases...

Completed

Study on the Safety and Immunogenicity of Boostrix Vaccine in Pregnant Malian Women and Their Infants

Pertussis | Tetanus | Diphtheria | Diphtheria Immunisation | Tetanus Immunisation | Clostridium Difficile Immunisation

Mali
National Institute of Allergy and Infectious Diseases...

Completed

Evaluating the Efficacy and Safety of Dolutegravir-Containing Versus Efavirenz-Containing Antiretroviral Therapy Regimens in HIV-1-Infected Pregnant Women and Their Infants (VESTED)

HIV Infections

United States, South Africa, Thailand, Botswana, Brazil, Tanzania, Zimbabwe, India, Uganda
National Institute of Allergy and Infectious Diseases...

Completed

Safety of and Immune Response to a Prime-Boost Vaccine Regimen in HIV-Uninfected Vaccine-Naive Adults

HIV Infections

United States, Peru
National Institute of Allergy and Infectious Diseases...

Completed

Evaluating the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Combinations of Monoclonal Antibodies PGT121, PGDM1400, 10-1074, and VRC07-523LS Administered Via Intravenous Infusion in Healthy, HIV-uninfected Adult Participants

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

Adaptive COVID-19 Treatment Trial 4 (ACTT-4)

COVID-19

United States, Japan, Mexico, Singapore, Korea, Republic of
National Institute of Allergy and Infectious Diseases...

Completed

A Study to Evaluate the Safety and Pharmacokinetics of NTM-1633 vs Placebo Administered Intravenously in Healthy Adults

Botulism

United States
National Institute of Allergy and Infectious Diseases...

Completed

Evaluating the Safety and Immunogenicity of HIV Clade C DNA Vaccine and MF59- or AS01B-Adjuvanted Clade C Env Protein Vaccines in Various Combinations in Healthy, HIV-Uninfected Adults

HIV Infections

United States, South Africa

Clinical Trials Sponsored by National Institute of Allergy and Infectious Diseases (NIAID)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Croatia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations